| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/09/2011 | US20110136748 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136730 "Method for screening compounds comprising the use of picornavirus protease 2A" |
| 06/09/2011 | US20110136729 Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans |
| 06/09/2011 | US20110136728 Methods of increasing bone formation using leptin-related peptides |
| 06/09/2011 | US20110136727 Compositions and methods for rapid selection of pathogen binding agents |
| 06/09/2011 | US20110136726 Novel antimicrobial agents |
| 06/09/2011 | US20110136221 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 06/09/2011 | US20110135769 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes |
| 06/09/2011 | US20110135761 Antimicrobial suture for medical use with grapefruit extract, and manufacturing method thereof |
| 06/09/2011 | US20110135754 Control of diseases in crops |
| 06/09/2011 | US20110135749 Low shrinkage multifunctional ssq resins |
| 06/09/2011 | US20110135742 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| 06/09/2011 | US20110135735 Process for production of a composite material having antimicrobial activity |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135720 Polymer coatings containing phytochemical agents and methods for making and using same |
| 06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
| 06/09/2011 | US20110135713 Antimicrobial and Antiviral Compounds and Methods for Their Use |
| 06/09/2011 | US20110135711 Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors |
| 06/09/2011 | US20110135703 Antimicrobial Coating for Surgical Implants and Method of Use |
| 06/09/2011 | US20110135695 Oral dosage form for controlled drug release |
| 06/09/2011 | US20110135691 Immunomodulation by iap inhibitors |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135686 Replication-Defective Flavivirus Vaccines and Vaccine Vectors |
| 06/09/2011 | US20110135685 Edible Vaccines Expressed in Soybeans |
| 06/09/2011 | US20110135684 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro |
| 06/09/2011 | US20110135683 Modified vaccinia virus ankara for the vaccnation of neonates |
| 06/09/2011 | US20110135682 Recombinant Bicistronic Flaviviruses and Methods of Use Thereof |
| 06/09/2011 | US20110135677 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 06/09/2011 | US20110135676 Novel antiviral peptide against avian influenza virus h9n2 |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135671 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135669 Synthetic agonists of tlr9 |
| 06/09/2011 | US20110135659 Fish Vaccine |
| 06/09/2011 | US20110135655 Role of PI3K p110 delta Signaling in Retroviral Infection and Replication |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135645 Human antibodies neutralizing human metapneumovirus |
| 06/09/2011 | US20110135642 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
| 06/09/2011 | US20110135634 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 06/09/2011 | US20110135625 Controlled release enzymatic composition and methods of use |
| 06/09/2011 | US20110135621 Inhibiting bacterial infection and biofilm formation |
| 06/09/2011 | US20110135615 Transiently buffered lactobacillus preparations and use thereof |
| 06/09/2011 | US20110135605 Methods and products related to treatment and prevention of hepatitis c virus infection |
| 06/09/2011 | US20110135599 Antiviral compounds |
| 06/09/2011 | US20110135598 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 06/09/2011 | US20110135595 Neuregulin based methods and compositions for treating cardiovascular disease |
| 06/09/2011 | US20110135593 Sterilizing polymer and method of preparation thereof |
| 06/09/2011 | US20110135580 Novel Medicament Combinations for the Treatment of Respiratory Diseases |
| 06/09/2011 | US20110135578 Mycobacterial infections |
| 06/09/2011 | US20110132376 Topical antiviral formulations |
| 06/09/2011 | US20110131928 Reduced-odor thiol compositions |
| 06/09/2011 | DE102009057267A1 Ointment, useful for treating Mortellaro's disease in cloven-hoofed animals, comprises a mixture of cereal hydrolyzate, acid whey and water, where the mixture is added with calcium chloride, magnesium chloride and iron saccharate |
| 06/09/2011 | CA2782631A1 Treatment of infectious diseases |
| 06/09/2011 | CA2782441A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
| 06/09/2011 | CA2781140A1 Proline derivatives |
| 06/08/2011 | EP2330219A2 Method for drug discovery, disease treatment and diagnosis using metabolomics |
| 06/08/2011 | EP2330194A2 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 06/08/2011 | EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 06/08/2011 | EP2330116A1 Replikin peptides and uses thereof |
| 06/08/2011 | EP2330115A1 Replikin peptides and uses thereof |
| 06/08/2011 | EP2330107A2 Improved production method for adefovir dipivoxil |
| 06/08/2011 | EP2329845A1 Avian influenza virus antigen, and booster immunization method for avian influenza vaccine in combination with mucosal adjuvant which is effective through oral administration |
| 06/08/2011 | EP2329842A2 Interleukin-1 inhibitors in the treatment of diseases |
| 06/08/2011 | EP2329836A1 Extracts obtained from hoodia gordonii cells lines, their preparation and use |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329819A1 Pharmaceutical composition for use in treating sexually transmitted infections |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2329717A1 Disinfectant and/or bactericidal aqueous compositions |
| 06/08/2011 | EP2328933A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection |
| 06/08/2011 | EP2328929A2 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases |
| 06/08/2011 | EP2328913A2 Antimicrobial protein compositions and production therefor from marine bacteria |
| 06/08/2011 | EP2328878A1 Triazole compounds, the use thereof and preparations containing these compounds |
| 06/08/2011 | EP2328865A1 Hepatitis c virus inhibitors |
| 06/08/2011 | EP2328656A1 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis " |
| 06/08/2011 | EP2328612A1 Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs) |
| 06/08/2011 | EP2328578A2 Noscapine and noscapine analogs and their use in treating infectious diseases by tubulin binding inhibition |
| 06/08/2011 | EP2328575A1 A novel standardized composition, method of manufacture and use in the resolution of rna virus infection |
| 06/08/2011 | EP2328573A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 06/08/2011 | EP2328569A1 Compositions and methods of treatment comprising ceftaroline |
| 06/08/2011 | EP1898900B1 Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
| 06/08/2011 | EP1531800B1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
| 06/08/2011 | EP1431293B1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/08/2011 | EP1259259B1 Mucosal adjuvant formulation |
| 06/08/2011 | EP0914142B1 Peptides with increased binding affinity for at least three hla-a3-like molecules |
| 06/08/2011 | CN1989966B Pharmaceutical composition comprising rifamoin and isoniazid |
| 06/08/2011 | CN1943697B Dermatophytosis liquid |
| 06/08/2011 | CN1895322B Jinganmin effervescent tablets and preparation thereof |
| 06/08/2011 | CN1852736B Immunoglobulin chimeric monomer-dimer hybrids |
| 06/08/2011 | CN1813919B Capsule for treating root and promoting transformation for heptitis B and its preparing process |
| 06/08/2011 | CN1651451B 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application |
| 06/08/2011 | CN102089324A Compositions and methods for the therapy and diagnosis of influenza |
| 06/08/2011 | CN102089318A Salts of HIV inhibitor compounds |
| 06/08/2011 | CN102089314A Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 06/08/2011 | CN102089313A 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 06/08/2011 | CN102089312A Salinosporamide derivatives as proteasome inhibitors |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |